Identification of RUNX1T1 as a potential epigenetic modifier in small‐cell lung cancer
Small‐cell lung cancer (SCLC) can be subgrouped into common ‘pure’ and rare ‘combined’ SCLC (c‐SCLC). c‐SCLC features a mixed tumor histology of both SCLC and non–small‐cell lung cancer (NSCLC). We performed targeted exome sequencing on 90 patients with SCLC, including two with c‐SCLC, and discovere...
Główni autorzy: | Tian He, Gary Wildey, Karen McColl, Alyssa Savadelis, Kyle Spainhower, Cassidy McColl, Adam Kresak, Aik Choon Tan, Michael Yang, Ata Abbas, Afshin Dowlati |
---|---|
Format: | Artykuł |
Język: | English |
Wydane: |
Wiley
2021-01-01
|
Seria: | Molecular Oncology |
Hasła przedmiotowe: | |
Dostęp online: | https://doi.org/10.1002/1878-0261.12829 |
Podobne zapisy
-
RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML
od: Justin Loke, i wsp.
Wydane: (2017-05-01) -
A RUNX1: RUNX1T1 AML with a simultaneous false positive KMT2A rearrangement: FISH interpretation pitfalls
od: Chi Zhang, i wsp.
Wydane: (2024-12-01) -
RUNX Proteins as Epigenetic Modulators in Cancer
od: Hongyang Yi, i wsp.
Wydane: (2022-11-01) -
Interplay between transcription factors and the epigenome: Insight from the role of RUNX1 in leukemia.
od: Kate Helen Brettingham-Moore, i wsp.
Wydane: (2015-09-01) -
Germline de novo alterations of RUNX1T1 in individuals with neurodevelopmental and congenital anomalies
od: Erfan Aref-Eshghi, i wsp.
Wydane: (2025-01-01)